Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Morrison

Showing results (991-1000 of 1,096) with videos related to

Pageof 110
Sort By:
Eclinicalmedicine|July 31, 2025
A core outcome set for research on masculinizing genital gender-affirming surgery: international consensus results from the GenderCOS projectPhilippine J Roijer, Marleen S Vallinga, Thomas E Pidgeon, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2014
Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxietyBrittney S Bates, Alice L Rodriguez, Andrew S Felts, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxietyAndrew S Felts, Alice L Rodriguez, Ryan D Morrison, et al.
Frontiers in Immunology|June 14, 2019
Disruption of Telomere Integrity and DNA Repair Machineries by KML001 Induces T Cell Senescence, Apoptosis, and Cellular DysfunctionsDechao Cao, Juan Zhao, Lam N Nguyan, et al.
Eclinicalmedicine|July 31, 2025
The core outcome set for studies on feminizing genital gender-affirming surgery: findings from the GenderCOS projectMarleen S Vallinga, Philippine J Roijer, Thomas E Pidgeon, et al.
Nature Communications|April 8, 2022
FGF21 is required for protein restriction to extend lifespan and improve metabolic health in male miceCristal M Hill, Diana C Albarado, Lucia G Coco, et al.
Molecular Cancer Therapeutics|May 7, 2020
Combined Targeting of the BRD4-NUT-p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734Chevaun D Morrison-Smith, Tatiana M Knox, Ivona Filic, et al.
Chemmedchem|April 3, 2014
Discovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probePatrick R Gentry, Masaya Kokubo, Thomas M Bridges, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2016
Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacyRocco D Gogliotti, Darren W Engers, Pedro M Garcia-Barrantes, et al.
Journal of Surgical Education|September 17, 2024
Conscientious Objection to Gender-Affirming Surgery: A Cross-Sectional Analysis of Plastic Surgery and Urology Residency ProgramsDanielle J Eble, Alisha L Nguyen, Cole V Roblee, et al.
Pageof 110

Showing results (991-1000 of 1,096) with videos related to

Sort By:
Pageof 110
Eclinicalmedicine|July 31, 2025
A core outcome set for research on masculinizing genital gender-affirming surgery: international consensus results from the GenderCOS projectPhilippine J Roijer, Marleen S Vallinga, Thomas E Pidgeon, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2014
Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxietyBrittney S Bates, Alice L Rodriguez, Andrew S Felts, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxietyAndrew S Felts, Alice L Rodriguez, Ryan D Morrison, et al.
Frontiers in Immunology|June 14, 2019
Disruption of Telomere Integrity and DNA Repair Machineries by KML001 Induces T Cell Senescence, Apoptosis, and Cellular DysfunctionsDechao Cao, Juan Zhao, Lam N Nguyan, et al.
Eclinicalmedicine|July 31, 2025
The core outcome set for studies on feminizing genital gender-affirming surgery: findings from the GenderCOS projectMarleen S Vallinga, Philippine J Roijer, Thomas E Pidgeon, et al.
Nature Communications|April 8, 2022
FGF21 is required for protein restriction to extend lifespan and improve metabolic health in male miceCristal M Hill, Diana C Albarado, Lucia G Coco, et al.
Molecular Cancer Therapeutics|May 7, 2020
Combined Targeting of the BRD4-NUT-p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734Chevaun D Morrison-Smith, Tatiana M Knox, Ivona Filic, et al.
Chemmedchem|April 3, 2014
Discovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probePatrick R Gentry, Masaya Kokubo, Thomas M Bridges, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2016
Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacyRocco D Gogliotti, Darren W Engers, Pedro M Garcia-Barrantes, et al.
Journal of Surgical Education|September 17, 2024
Conscientious Objection to Gender-Affirming Surgery: A Cross-Sectional Analysis of Plastic Surgery and Urology Residency ProgramsDanielle J Eble, Alisha L Nguyen, Cole V Roblee, et al.
Pageof 110